Value of the <scp>HFA‐PEFF</scp> and <scp> H <sub>2</sub> FPEF </scp> scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis
Daniela Tomasoni(University of Brescia), Marco Metra(GoHypersonic (United States)), Carlo Lombardi(Fondazione Poliambulanza Istituto Ospedaliero), Michele Emdin(Scuola Superiore Sant'Anna), Gianfranco Sinagra(University of Trieste), Giuseppe Vergaro(Scuola Superiore Sant'Anna), Giorgia Panichella(Scuola Superiore Sant'Anna), Dario Cani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Anas Khalil(Scuola Superiore Sant'Anna), Marianna Adamo, Maria Franzini(University of Pisa), Aldostefano Porcari(University of Trieste), Marco Merlo(Ospedale Policlinico San Martino), Alberto Aimo(Scuola Superiore Sant'Anna), Maddalena Rossi(University of Trieste), Matilde Nardi(Surgical Specialties (Canada)), Edoardo Pancaldi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Maria Giulia Bellicini(Surgical Specialties (Canada)), Claudio Rapezzi(Boston University)
Cited by 43
Related Papers
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k